Sort Results:
List of Materials
 |
"AI Ate My Homework" summer lecture series
"AI Ate My Homework" summer lecture series by Cyclica. Artificial Intelligence, machine learning, and neural networks are all the range in drug discovery. This playlist includes seven webinars from Cyclica’s summer series, with... |
Cyclica, Inc. Presenter: Cyclica, Inc. |
 |
A High-Throughput, Accurate Mass Approach for Plasma Protein Binding Analysis Using SPE/TOF-MSAn ultafast SPE/TOF/MS method was developed to analyze plasma protein binding assay samples at a rate of 9 sec per sample. This ultrafast, high resolution approach may be useful for the analysis of other in vitro ADME assays |
Agilent Technologies Presenter: Agilent Technologies |
 |
Academic Drug Discovery in the Center for Integrative Chemical Biology and Drug DiscoveryLearn more about the Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina Chapel Hill . This presentation discusses the Center's vision, mission, capabilities, process and portfolio and highlights. ' |
Center for Integrative Chemical Biology and Drug Discovery University of North Carolina Chapel Hill Presenter: Stephen V. Frye, Ph.D. |
|
Academics in CNS Therapy DiscoveryThe business of drug discovery is changing. Pharma has historically played the principal role in small molecule drug development, and academia has traditionally conducted the basic research studies, providing pharma with the molecular targets to... |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Barbara Slusher, Ph.D., M.A.S. |
|
Accelerating Drug Discovery for Alzheimer’s Disease: Best Practices for Preclinical Animal Studies
|
Charles River Presenter: Charles River |
|
Addressing Irreproducibility Presentations: Academic Drug Discovery: Where the Rubber Meets the RoadStephen Frye was a presenter at the ADDC/AGM Symposium Addressing Irreproducibility in Target Validation. Stephen was addressing the academic and industrial drug discovery experience and solutions in this ongoing issue. |
Center for Integrative Chemical Biology and Drug Discovery UNC Chapel Hill Presenter: Stephen V. Frye, Ph.D. |
|
Addressing Irreproducibility Presentations: Data Reproducibility: An Editor’s PerspectiveAngel Colmone was a presenter at the ADDC/AGM Symposium Addressing Irreproducibility in Target Validation. Angela was addressing the roles of journals in this ongoing issue. |
Science Translational Medicine Presenter: Angela Colmone, Ph.D. |
|
Addressing Irreproducibility Presentations: Defining the ProblemShai Silberberg was a presenter at the ADDC/AGM Symposium Addressing Irreproducibility in Target Validation. Shai was defining the problem to begin the symposium. |
NINDS/NIH Presenter: Shai Silberberg |
|
Addressing Irreproducibility Presentations: Defining the Problem: Case Histories in ALSFernando Vieira was a presenter at the ADDC/AGM Symposium Addressing Irreproducibility in Target Validation. Fernando was sharing case studies in ALS. |
ALS-TDI ALS-Therapy Development Institute Presenter: Fernando Vieira |
|
Addressing Irreproducibility Presentations: Enhancing Reproducibility and Transparency of Research Findings: The Role of NIHDorit Zuk was a presenter at the ADDC/AGM Symposium Addressing
Irreproducibility in Target Validation. Dorit was addressing the role of the NIH in addressing this issue of |
Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences (NCATS) National Institutes of Health Presenter: Dorit Zuk, Ph.D. |